These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3391225

  • 1. Effects of the mass screenings for neuroblastoma in Japan. A study of 68 cases.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Eur J Pediatr; 1988 Apr; 147(3):308-11. PubMed ID: 3391225
    [Abstract] [Full Text] [Related]

  • 2. Mass screening of neuroblastoma in infancy.
    Sawada T, Todo S, Fujita K, Iino S, Imashuku S, Kusunoki T.
    Am J Dis Child; 1982 Aug; 136(8):710-2. PubMed ID: 6808827
    [Abstract] [Full Text] [Related]

  • 3. Mass screening of neuroblastoma in Sapporo City, Japan.
    Nishi M, Miyake H, Takeda T, Kikuchi Y, Hanai J, Yonemori H, Takasugi N.
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
    [Abstract] [Full Text] [Related]

  • 4. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F, Hashizume K, Nakajo T, Kamoshita S.
    J Pediatr; 1991 Aug; 119(2):237-41. PubMed ID: 1861208
    [Abstract] [Full Text] [Related]

  • 5. Number and cure rate of neuroblastoma cases detected by the mass screening program in Japan: future aspects.
    Sawada T, Sugimoto T, Tanaka T, Kawakatsu H, Ishii T, Matsumura T, Horii Y.
    Med Pediatr Oncol; 1987 Aug; 15(1):14-7. PubMed ID: 3561327
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
    Sawada T, Hirayama M, Nakata T, Takeda T, Takasugi N, Mori T, Maeda K, Koide R, Hanawa Y, Tsunoda A.
    Lancet; 1984 Aug 04; 2(8397):271-3. PubMed ID: 6146820
    [Abstract] [Full Text] [Related]

  • 8. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 04; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 9. Problems of neuroblastoma screening for 6 month olds and results of second screening for 18 month olds.
    Hayashi Y, Ohi R, Yaoita S, Nakamura M, Kikuchi Y, Konno T, Tsuchiya S, Shiraishi H.
    J Pediatr Surg; 1995 Mar 04; 30(3):467-70. PubMed ID: 7760244
    [Abstract] [Full Text] [Related]

  • 10. Japanese experience of screening.
    Takeda T, Hatae Y, Nakadate H, Nishi M, Hanai J, Sato Y, Takasugi N.
    Med Pediatr Oncol; 1989 Mar 04; 17(5):368-72. PubMed ID: 2796852
    [Abstract] [Full Text] [Related]

  • 11. Mass screening for neuroblastoma in Japan.
    Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y.
    Pediatr Hematol Oncol; 1991 Mar 04; 8(2):93-109. PubMed ID: 1863547
    [Abstract] [Full Text] [Related]

  • 12. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
    Murphy SB, Cohn SL, Craft AW, Woods WG, Sawada T, Castleberry RP, Levy HL, Prorok PC, Hammond GD.
    Lancet; 1991 Feb 09; 337(8737):344-6. PubMed ID: 1671243
    [No Abstract] [Full Text] [Related]

  • 13. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
    Yokoyama S, Hirakawa H, Ueno S, Yabe H, Hiraoka N.
    Pediatrics; 1999 May 09; 103(5):e67. PubMed ID: 10224211
    [Abstract] [Full Text] [Related]

  • 14. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T.
    Cancer; 1984 Jun 15; 53(12):2731-5. PubMed ID: 6722733
    [Abstract] [Full Text] [Related]

  • 15. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
    Berthold F, Baillot A, Hero B, Schurr P, Nerenz A, Hunneman DH, Sander J.
    J Clin Oncol; 1999 Apr 15; 17(4):1200. PubMed ID: 10561179
    [Abstract] [Full Text] [Related]

  • 16. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Sep 15; 17(3):221-8. PubMed ID: 3669365
    [Abstract] [Full Text] [Related]

  • 17. Mass screening for neuroblastoma and mortality in birth cohorts.
    Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Takasugi N.
    Int J Cancer; 1997 May 16; 71(4):552-5. PubMed ID: 9178807
    [Abstract] [Full Text] [Related]

  • 18. Mass-screening of neuroblastoma using urine from infants by high-performance liquid chromatographic method: results of first (6th month) and second (14th month) screening.
    Takeda T, Shimada M, Nishi M, Hanai J, Kikuchi Y.
    J Neurooncol; 1997 Jan 16; 31(1-2):165-70. PubMed ID: 9049845
    [Abstract] [Full Text] [Related]

  • 19. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T, Nagahara N, Ohi R, Yamamoto K, Okabe I, Hanawa Y, Hashizume K, Matsui I, Ohkawa H, Tunoda A.
    Gan To Kagaku Ryoho; 1990 Dec 16; 17(12):2319-26. PubMed ID: 2260868
    [Abstract] [Full Text] [Related]

  • 20. Incidence of neuroblastoma in infancy in Japan.
    Sawada T, Kidowaki T, Sugimoto T, Kusunoki T.
    Med Pediatr Oncol; 1984 Dec 16; 12(2):101-3. PubMed ID: 6700544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.